• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

Gradiente buys Arcansas

  • Alessia Argentieri
  • Alessia Argentieri
  • 04 September 2020
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Private equity firm Gradiente has acquired Arcansas, an Italian manufacturer of profiles for walls and floors.

The GP backed the business alongside investment holding company La Finanziaria Trentina. They bought a stake of around 60%, while the remainder was retained by the founding Scriattoli family.

Gradiente plans to support the organic growth of the company, by expanding its retail channels and doubling its revenues, while pursuing a buy-and-build strategy with acquisitions of Italian and international companies operating in complementary segments of the market.

Arcansas

  • DEAL:

    Buyout

  • LOCATION:

    Terre Roveresche

  • SECTOR:

    Durable household products

  • FOUNDED:

    1980

  • TURNOVER:

    €30m (2019)

  • EBITDA:

    €7m (2019)

  • STAFF:

    100

Banco BPM provided a debt package to support the transaction, with Simmons & Simmons acting as legal adviser to the lender.

The GP deployed capital from Gradiente II, which held a final close on its €135m hard-cap, surpassing its €120m initial target, in February 2019.

This is the fourth investment made by the fund, following the purchase of metal components producer HPF; the acquisition of an 80% stake in fridges manufacturer Cold Line, which was sold to Nice Group in May 2019; and the recent purchase of three companies specialising in surface coating: Argos, Aalberts Surface Treatment Italy and Impreglon Italia.

Company
Established in 1980, Arcansas is a manufacturer of profiles for walls and floors. Its products are designed to join and protect the outer corners of ceramic tiles, and also to decorate and enhance wall and floor coverings, and the laying of mosaics and tiles.

The company employs 100 staff and generates EBITDA of around €7m from annual revenues of €30m, of which 50% comes from outside Italy.

Arcansas is headquartered in Terre Roveresche, with two production plants located in Mondavio and Piagge, five additional branches outside Italy and operations in 30 countries worldwide.

People
Gradiente
– Carlo Bortolozzo, Pietro Busnardo (founding partners).
Arcansas – Amedeo Scriattoli (CEO).

Advisers
Equity – NCTM (legal); Russo De Rosa (tax); PwC (financial due diligence); GEA Consulenti (operational due diligence); Marsh Risk Consulting (environmental due diligence).
Company – Studio Guerra & Associati (tax); Ceccarelli & Silverstri (legal).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • Southern Europe
  • Consumer
  • Italy

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013